Matarin Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,056
| Closed | -$3.64M | – | 216 |
|
|
2019
Q4 | $3.64M | Sell |
12,056
-7,573
| -39% | -$2.29M | 0.35% | 131 |
|
|
2019
Q3 | $4.71M | Sell |
19,629
-34
| -0.2% | -$8.16K | 0.36% | 103 |
|
|
2019
Q2 | $5.55M | Hold |
19,663
| – | – | 0.4% | 95 |
|
|
2019
Q1 | $5.64M | Sell |
19,663
-13
| -0.1% | -$3.73K | 0.41% | 92 |
|
|
2018
Q4 | $5.17M | Sell |
19,676
-2,609
| -12% | -$685K | 0.42% | 86 |
|
|
2018
Q3 | $6.11M | Buy |
22,285
+4,923
| +28% | +$1.35M | 0.39% | 92 |
|
|
2018
Q2 | $4.13M | Sell |
17,362
-3,442
| -17% | -$819K | 0.3% | 114 |
|
|
2018
Q1 | $4.57M | Sell |
20,804
-4,111
| -17% | -$903K | 0.34% | 105 |
|
|
2017
Q4 | $5.61M | Hold |
24,915
| – | – | 0.44% | 84 |
|
|
2017
Q3 | $4.73M | Sell |
24,915
-7,284
| -23% | -$1.38M | 0.4% | 100 |
|
|
2017
Q2 | $6.06M | Buy |
32,199
+4,286
| +15% | +$806K | 0.56% | 75 |
|
|
2017
Q1 | $4.62M | Sell |
27,913
-1,118
| -4% | -$185K | 0.45% | 82 |
|
|
2016
Q4 | $4.17M | Sell |
29,031
-13,594
| -32% | -$1.95M | 0.47% | 77 |
|
|
2016
Q3 | $5.34M | Buy |
42,625
+13,858
| +48% | +$1.74M | 0.59% | 79 |
|
|
2016
Q2 | $3.78M | Buy |
28,767
+4,321
| +18% | +$568K | 0.51% | 89 |
|
|
2016
Q1 | $3.4M | Sell |
24,446
-1,694
| -6% | -$235K | 0.47% | 92 |
|
|
2015
Q4 | $3.64M | Buy |
26,140
+17,443
| +201% | +$2.43M | 0.55% | 86 |
|
|
2015
Q3 | $1.22M | Sell |
8,697
-4,230
| -33% | -$592K | 0.25% | 123 |
|
|
2015
Q2 | $2.12M | Sell |
12,927
-102
| -0.8% | -$16.7K | 0.61% | 72 |
|
|
2015
Q1 | $2.01M | Buy |
+13,029
| New | +$2.01M | 0.61% | 73 |
|
|
2014
Q4 | – | Sell |
-9,334
| Closed | -$1.12M | – | 157 |
|
|
2014
Q3 | $1.12M | Buy |
9,334
+7,244
| +347% | +$867K | 0.51% | 93 |
|
|
2014
Q2 | $225K | Buy |
+2,090
| New | +$225K | 0.1% | 160 |
|
|
2013
Q4 | – | Sell |
-3,018
| Closed | -$252K | – | 134 |
|
|
2013
Q3 | $252K | Buy |
+3,018
| New | +$252K | 0.21% | 147 |
|